← Evidence map

ArticleStatistics in medicine2023

Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution.

Virginia B Shipes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution. | OpenQuestion